干细胞之家 - 中国干细胞行业门户第一站
标题:
干细胞基础研究和临床应用最新进展的综述文献，供大家参考
[打印本页]
作者:
tangdi
时间:
2009-10-29 19:08
标题:
干细胞基础研究和临床应用最新进展的综述文献，供大家参考
A review of gene and stem cell therapy in cutaneous wound healing
3 ?8 U8 ]+ Z, V. Q' w
A Stem Cell Niche for Intermediate Progenitor Cells of the Embryonic Cortex
9 j: E E# i9 V0 d' z v; n
Acute Complications of Stem Cell Transplant
: ~' E! i: a, A% W7 C% ~" B6 u
Adhesion within the stem cell niches
, W6 Z7 R; S7 k( N
Allogeneic Stem Cell Transplantation Is Able to Induce Long-Term Remissions in Angioimmunoblastic T-Cell Lymphoma
2 ^: } u% M- l, R
Beliefs About Science and News Frames in Audience Evaluations of Embryonic and Adult Stem Cell Research
0 ?- A$ R2 N4 j/ N, A/ L) J
bone-What is the true nature of the osteoblastic hematopoietic stem cell niche
" O* T8 n7 V* v8 O! H+ R. ~, g9 w4 [
Apoptosis signaling in cancer stem cells
. R% l" q5 `4 I" l& `
Nonmyeloablative and Reduced-Intensity Conditioning for Allogeneic Hematopoietic Stem Cell Transplantation
0 N9 e% p: h5 X1 @
Recurrence cancer stem cells
0 z3 p8 L, Q0 r, S
Stem cells in melanoma development
# C8 Z* Y( Y* Y0 h4 d" l
Competitive Interactions Between Cells
% b# _4 b6 m# C) l2 w
Cord blood stem cells for hematopoietic stem cell transplantation in the UK
& W9 U5 E& x& b# k# X! w5 K) H' U6 i% @
A chronic 1 year assessment of MRI contrast agent-labelled neural stem cell transplants in stroke
0 X4 z5 B7 F# @* [
Cardiac stem-progenitor cells, secreted proteins, and proteomics
, k. y6 `# ~. N
Cardiovascular stem cells in regenerative medicine
0 B" A$ g9 ^, v
Endogenous stem cells in patients undergoing coronary artery bypass
0 `& q& s4 \: R
Enhancing cardiac stem cell differentiation into cardiomyocytes
2 C' ?' c5 v# ]& P- q
In Vivo Imaging of Stem Cells and Beta Cells Using Direct Cell Labeling and Reporter Gene Methods
7 p% R9 u5 O* Z! x8 G
Resident cardiac stem-progenitor cells for cardiac regeneration
$ E: ~+ r9 U, Q- k
S1+ Stem Cell Survival and Engraftment in the Infarcted Heart
: v8 h! f% x5 c4 n8 T8 Z4 X
Stem cell engineering for treatment of heart diseases
+ a. m @9 Y x. A
Stem cell therapy in acute myocardial infarction
; z- Z3 ^' ~( V- [7 ^
Stem Cell Therapy Is Proarrhythmic
5 L/ v6 _$ h0 S6 K% M+ f$ P8 Q
Stem Cell Therapy-A Primer for Interventionalists and Imagers
% B# X: z$ w6 N) R! j+ ]
diabetes-Mesenchymal stem cells-Stem cell therapy perspectives for type 1 diabetes
$ c5 f `% [' U; P
Embryonic stem cells as a model for cardiac development and disease
/ A8 W8 ]* @6 T$ w( H
Epigenetic dynamics of stem cells and cell lineage commitment
/ `# _' ^& F4 u, k- L; |, r# \
Epileptic Spasms After Stem Cell Transplantation for Chronic Epstein-Barr Virus Infection
* t8 X/ v" m4 [
Expanding Indications for Stem Cell Transplantation
: j" I3 w& u' ]- \$ z) ]
Fatal nephrotic syndrome complicating allogeneic stem cell transplantation
$ I1 Q4 K4 ]. }+ t8 q9 J
Growth Factors, Matrices, and Forces Combine and Control Stem Cells
9 p8 x! q4 p+ p n3 a
Hematopoietic stem cell origin of adipocytes
# F* {$ c2 w( @
Hepatic response after high-dose melphalan and stem cell transplantation in patients with AL amyloidosis
8 l+ ?8 \& R- g3 ^
Long-term microcarrier suspension cultures of human embryonic stem cells
7 ^! {4 z% N' {1 V! j
Microsphere-based tracing and molecular delivery in embryonic stem cells
) ~2 a$ `/ D" Q7 N/ A3 a7 `4 F* f
Microspheres as a vehicle for biomolecule delivery to neural stem cells
# p4 J* ]1 [1 j. G8 }& a
New insights into liver stem cells
; G U( n' B' L
A NEUROSURGEON'S GUIDE TO STEM CELLS, CANCER STEM CELLS, AND BRAIN TUMOR STEM CELLS
/ v0 w. j# T$ i$ I7 d7 l
Regeneration of the ischemic brain by engineered stem cells
8 `9 s: N) @" u6 D" @
Stem cell-based cell replacement strategies for the central nervous system
$ \$ ~* _8 w; _6 g: q [
Percutaneous intramyocardial stem cell injection in patients with acute myocardial infarction
. E7 a- @- t/ M
Peripheral blood stem cell mobilisation by granulocyte-colony stimulating factor in patients with acute and old myocardial infarction
& m2 U5 o; ]) F; T% o9 l0 e9 v6 y9 _
Pluripotent stem cells as new drugs
, f6 X& {' V- T' c9 E0 }
regenerative-The complexity of cellular dedifferentiation-implications for regenerative medicine
/ u* o3 v$ r+ |% L( w
respir-Cell therapy approaches for lung diseases
^/ Z7 z9 g! p2 h
Risk factors for therapy-related myelodysplastic syndrome and acute myeloid leukemia treated with allogeneic stem cell transplantation
p- h8 m P' L) z
Role of epigenetics in liver-specific gene transcription, hepatocyte differentiation and stem cell reprogrammation
- j. n4 i8 ?6 }: ~
Role of Hematopoietic Stem Cell Transplant in the Management of Follicular Lymphoma
; o$ Z! D' a! z/ G4 l3 L
Status of adult marrow stem cell biology
% p: N' ?/ t- b" b& @/ D; p
Stem cell and genetic therapies for the fetus
$ Q# j6 _& l" Y: r
Stem cell decision making and critical-like exploratory networks
% t& G) C: @9 ^; N, k0 ~
Stem Cell Therapy for Heart Failure
% |( z# n+ E( g: R+ @0 _
Stem Cell Therapy for the Kidney
+ b" [- i# [8 j ~
Stem Cells and Liver Regeneration
; v$ q+ t: j6 `2 X' c; q
Stem cells, microenvironment mechanics, and growth factor activation
! J/ o+ B+ i5 X# x
Stem cells-The highs and lows of pluripotency
1 I* y6 \ y; t1 ?. i6 ~6 C
Successful unrelated donor stem cell transplantation for advanced myelofibrosis in an adult patient with history of orthotopic liver transplantation
+ T& C+ Z8 a# l, d* d2 K6 J1 n
Survivorship Issues in Hematopoietic Stem Cell Transplantation
8 i' a% c9 e8 V+ q5 g
Telomere length maintenance in stem cell populations
' v+ I5 q }% c/ h/ T4 Z
Teratoma formation by human embryonic stem cells
5 d7 v& ~$ j2 N$ w
The Development of Inflammatory Arthritis and Other Rheumatic Diseases Following Stem Cell Transplantation
n' o0 f ~: C+ v
The Increasing Complexity of the Cancer Stem Cell Paradigm
. F$ V0 X' [5 c+ M% k P
The therapeutic potential of bone marrow-derived mesenchymal stem cells on hepatic cirrhosis
2 _1 m4 h# z: g# E
Transcripts of unknown function in multiple-signaling pathways involved in human stem cell differentiation
% }. V4 u) a% U, F6 Y% L
Variation in the safety of induced pluripotent stem cell lines
4 S$ J0 c4 t- N- c8 A6 t
A niche play for stem cells
3 y# \9 ]! c5 A+ x2 t8 N8 Q
A niche play for stem cells
2 v9 k* A) X! f, Z# p9 e: k$ i! [
A parallel circuit of LIF signalling pathways maintains pluripotency of mouse ES cells
0 L! t5 n* T' v0 L4 ?% w0 p
Acute Complications of Stem Cell Transplant
& B; H7 c, u) O* j( O
Adipose-Derived Stem Cells
9 n3 F: ?8 L2 C. P- g9 N K
Adult neural stem cells in the mammalian central nervous system
" ]! i F. C( g$ {: s
Apoptosis Signaling in Cancer Stem Cells
7 h" H, P* T8 N, c f% Z
Automated selection and collection of pluripotent stem cell colonies using the CellCelector
j& m) w% v+ W u+ C
BCOR regulates mesenchymal stem cell function by epigenetic mechanisms
% w$ ^. S) v0 e' A/ G
Bmi-1, stem cells and cancer
- ]1 F1 q* g2 t7 ^2 C" [
cancer stem cell marker
! `% I5 b$ N3 |+ u" S! ^1 [
Cancer stem cells
* i; L! H6 b( p
Clinical Applications of Blood-Derived and Marrow-Derived Stem Cells for Nonmalignant Diseases
. \2 ^- J4 g+ z3 \3 n
Competitive Interactions Between Cells-Death, Growth, and Geography
, f2 Y$ I; A$ K0 l5 P6 ?
Potential novel pharmacological therapies for myocardial remodelling
& T2 D( x6 v2 z7 L
Disease-corrected haematopoietic progenitors from Fanconi anaemia induced pluripotent stem cells
n( t* B7 S# o8 |
Elite and stochastic models for induced pluripotent stem cell generation
6 S& P3 u0 U7 Z% |- O9 o
Embryonic stem (ES) cell-derived cardiomyocytes
4 d. Q0 @1 G: o
Emerging Immunology of Stem Cell Transplantation
* M. z2 [2 U7 E p) p' J$ r) N
Ethical Issues in Stem Cell Research
I' S" ]( P7 z' f' H9 z8 O
FDA Regulation of Stem Cell Based Products
# j3 o: @4 B' z9 x9 w V3 h* N
Growth Factors, Matrices, and Forces Combine and Control Stem Cells
* k7 f: z' J% _2 G; X
Human embryonic stem cells and cardiac repair
8 R* ]- l3 v/ W/ s3 Y; K
Human Fetal Membranes-A Source of Stem Cells for Tissue Regeneration and Repair
- f1 J( Z- n4 P; a, ?9 J% t
Human ISL1 heart progenitors generate diverse multipotent cardiovascular cell lineages
/ H; K2 D% z' J6 r' l! P
IFN-wakes up sleeping hematopoietic stem cells
3 k1 s% `) G/ _" p6 s$ D( e9 z
Imaging Stem Cell Implant for Cellular-Based Therapies
; o5 j& Y5 _! Z6 _2 Y+ F# F6 e* f
Implications of the Cancer Stem-Cell Hypothesis for Breast Cancer Prevention and Therapy
! t# b4 @) F* `/ r
Induced pluripotent stem cells and the stability of the differentiated state
% Z% T9 o& }* j8 u1 U0 w9 l
Instructing an Embryonic Stem Cell-Derived Oocyte Fate
% k5 f3 a% s Y. V8 @) `
Medical Innovation Versus Stem Cell Tourism
* h1 m( @% u3 z ~
In Search of Adrenocortical Stem and Progenitor Cells
% G9 s+ y# l$ ~. B5 N
Neural stem cells aplenty
2 q7 J; s$ x/ y5 K! \
Pancreatic cancer stem cells
# _9 b2 G) V) ^7 U0 A
Paracrine Mechanisms in Adult Stem Cell Signaling and Therapy
9 ?% k$ o* S5 r5 |
Psychological Issues of Stem Cell Transplant
) g- y5 j+ b2 C2 ]" `: G
Regeneration of the ischemic brain by engineered stem cells
1 t2 D9 Q$ n( U
Regulatory circuits underlying pluripotency and reprogramming
J! ^) |" F3 g) K
respir-Cell therapy approaches for lung diseases
6 {) @* d& @8 P0 T) J
Role of epigenetics in liver-specific gene transcription, hepatocyte differentiation and stem cell reprogrammation
, d5 V& u9 }; l4 f' h' C( e, Y9 `: D
specific microRNAs promote induced pluripotency
* |9 d/ V/ H) M% x1 x, D3 }4 y
Stem Cell Therapy for the Kidney
4 _7 f( M4 g @0 S
stem cell therapy in cutaneous wound healing
( _5 m# N+ l! _7 U
Stem cell therapy perspectives for type 1 diabetes
; f( Y8 P4 Z b4 G# i# n7 Z
Stem Cells and Liver Regeneration
$ }; r- w6 P' R5 H0 Q( V
Stem cells based transplantation for cardiovascular diseases in China
& q$ d* I/ o" o1 ?
Stem-cell therapy faces more scrutiny in China
7 f M8 ^: x' l
Steps to the Clinic
0 a) \( e5 h4 K7 l0 {/ u6 U
Stepwise differentiation of pluripotent stem cells into retinal cells
# _1 ], Q3 W1 o- E% L0 g, U, a
Sustained in vitro intestinal epithelial culture within a Wnt-dependent stem cell niche
5 ~, x+ S6 f& Z4 K8 X+ d. I
The Increasing Complexity of the Cancer Stem Cell Paradigm
" B9 w& A6 }. M$ E: r* J
The NIH Draft Guidelines on Human Stem Cell Research
: M7 |3 S$ u; W! C e+ v0 g
The pluripotency factor Oct4 interacts with Ctcf and also controls X-chromosome pairing and counting
, h( Q, O' _& m7 s
The Role of Stromal Stem Cells in Tissue Regeneration and Wound Repair
3 O! l. ]( [6 J6 h9 t& [
The tumor stem cell concept
0 b6 y: Q o. M
Umbilical cord blood stem cells-Towards a proteomic approach
9 [ l+ ^+ {- S, r5 U7 m
US regulator wades into stem cell therapies for heart disease
& o- O; F/ I7 e5 X0 q0 p; c7 t
Apoptosis Signaling in Cancer Stem Cells
) |! s1 f/ | H$ d9 m2 C
Pancreatic cancer stem cells
|* q# o, l( c' u6 {, S
Acute Complications of Stem Cell Transplant
3 Y# ]* P. _1 o9 c6 ]- Q& s
Autologous Stem-Cell Transplantation in Patients With HIV-Related Lymphoma
8 L7 f+ q; d$ A7 o
Deconstructing Stem Cell Tumorigenicity-A Roadmap to Safe Regenerative Medicine
9 B9 g1 w3 [7 z: v! L' J
Emerging Immunology of Stem Cell Transplantation
4 {4 s) b. H- t' H/ ?
Management Issues In Hematopoietic Stem Cell Transplantation
& e* ]* b. v/ A7 P
Psychological Issues of Stem Cell Transplant
* c% y' k1 G/ m* ]% ?. T' S( d+ _
The NIH Draft Guidelines on Human Stem Cell Research
6 h5 J8 @2 U1 Q1 r% T6 A
The therapeutic potential of bone marrow-derived mesenchymal stem cells on hepatic cirrhosis
, R0 u+ R: _+ r" X' [" j5 E
Bone Marrow-derived Stem-Progenitor Cells-Their Use in Clinical Studies for the Treatment of Myocardial Infarction
$ M8 M2 \% z }2 e
Embryonic stem (ES) cell-derived cardiomyocytes
/ N) X5 Q }8 A% d7 n* o3 u1 o
Embryonic stem cells as a model for cardiac development and disease
- S; C* I0 g1 [& F$ _, m ?+ R
Endogenous stem cells in patients undergoing coronary artery bypass graft surgery
3 b- ?5 W6 } j1 H" Y9 h
Human embryonic stem cells and cardiac repair
' c3 t: b7 s" V# E
Percutaneous intramyocardial stem cell injection in patients with acute myocardial infarction
! {3 N& C; E: j/ w% M" C
Promise of Blood-and Bone Marrow-Derived Stem Cell Transplantation for Functional Cardiac Repair
' T- N) D* I( U4 z0 y
Stem Cell Therapy for Heart Failure
% c. F! }. ]" e5 G7 y+ a
Epithelial metaplasia-adult stem cell reprogramming and (pre)neoplastic transformation mediated by inflammation
! @" i3 g" _9 k- u( H& w
Full text access provided to Peking university
3 L. I) @ r9 D+ a. f1 N' C2 a
Improving stem cell mobilization strategies-future directions
# ?+ f2 {, S* M/ m7 g3 I8 o0 \
Induced pluripotent stem cells from a spinal muscular atrophy patient
/ i0 R6 S' n9 X4 G$ j9 k$ p$ P
Induced pluripotent stem cells-current progress and potential for regenerative medicine
' N3 O- c" r( D2 a
Interferon regulatory factor-2 protects quiescent hematopoietic stem cells from type I interferon鈥揹ependent exhaustion
5 B, n2 u; x7 v: T
Low-risk reprogramming
5 m3 S5 L1 e+ Z& s: Q1 Z F
Molecular cues for pluripotency, genetic reprogramming of adult stem cells, and widely multipotent adult cells
" j( I' y; m6 u- ^0 W% N8 {2 r
piggyBac transposition reprograms fibroblasts to induced pluripotent stem cells
: l* G6 [4 r* K6 [9 X
Pluripotent stem cells as new drugs
6 Q& b0 N- O4 z+ w6 n# g; c2 X
proteome-Umbilical cord blood stem cells-Towards a proteomic approach
! v. \; T, R3 z& k4 @6 m
Regeneration of the ischemic brain by engineered stem cells
3 y" e+ m9 | }
Researchers Generally Happy With Final Stem Cell Rules
: S0 p, u/ N m3 A7 n
Stem Cell Niche
& w" m1 U0 [; ~6 ?; _, b) n
Stem cell therapy perspectives for type 1 diabetes
" X6 p& @3 p" z4 A
Stem Cells and Liver Regeneration
! e+ V% q9 Y F3 }2 F$ |0 t( _" m
Stem cells-Fast and furious
7 T4 q( F) a9 {) v& O7 \: T# f8 Q; d
Survivorship Issues in Hematopoietic Stem Cell Transplantation
5 w. \* h* x: r$ C! G
The NIH Draft Guidelines on Human Stem Cell Research
0 g5 T/ o# G5 h$ ]$ b
The origins of the identification and isolation of hematopoietic stem cells, and their capability to induce donor-specific transplantation tolerance and treat autoimmune diseases
6 S M7 k& ^4 v/ v0 b9 K% f
US stem-cell research expands
9 g+ X: h4 r+ P1 L+ e
Virus-free induction of pluripotency and subsequent excision of reprogramming factors
5 W; v. v; c" L; L; L
Wnt Signaling, Lgr5, and Stem Cells in the Intestine and Skin
作者:
guanjiyu
时间:
2009-11-8 14:39
谢谢！
作者:
ywta5156
时间:
2009-11-9 14:28
谢谢楼主
欢迎光临 干细胞之家 - 中国干细胞行业门户第一站 (http://www.stemcell8.cn/)
Powered by Discuz! X1.5